Personally committed to protecting your rights.
Picture of Robin P. Lourie

Taxotere

What is Taxotere?

Taxotere is a chemotherapy drug used to treat cancer, primarily breast cancer. Taxotere, manufactured by Sanofi Aventis, a French based corporation, was first approved for use in the United States in 1996 and it quickly rose in use to almost 75% of breast cancer patients.

What is the Problem With Taxotere?

Taxotere has been shown to cause permanent hair loss. The manufacturer of Taxotere gave warnings to consumers in countries other than the United States about permanent hair loss. However, it was not until 2015 when the FDA required the manufacturer to add a warning of permanent hair loss, that physicians and consumers of this drug in the United States were warned about this risk. While hair loss with the use of chemotherapy drugs is common, the hair typically grows back within 3-6 months of the end of treatment. Many users of Taxotere have loss of hair that never grows back.

Sanofi Aventis marketed Taxotere as being more effective than other breast cancer chemotherapy drugs, yet some studies have shown otherwise. Sanofi Aventis has sold over $1 billion worth of Taxotere per year since 2004.

Currently, a multi district litigation lawsuit has been filed in the state of Louisiana. This suit alleges that the manufacturer had knowledge of the risk of permanent hair lass and failed to disclose this risk to doctors and patients. If you have suffered permanent hair loss as a result of the use of Taxotere and would like a free evaluation, fill out the form below.

What is Multi District Litigation (MDL)?

Multi District Litigation, commonly abbreviated as MDL, is a means for consolidating lawsuits that are pending all over the country against a manufacturer of a product. The purpose of the MDL is for claimants to join forces to better be able to fight against huge pharmaceutical companies, medical device manufacturers, and other manufacturers, which have unlimited resources. MDLs pend in Federal District Courts of various states throughout the United States, but there is only one MDL for a particular product. It is not necessary for a claimant to live in the state where the MDL is pending or have any connection to that state in order to file a case in the MDL. The Federal Court judge directs the MDL and guides both sides through the discovery process, which includes gathering thousands of documents, taking numerous depositions of key witnesses in the litigation, and hiring experts to testify and support the plaintiffs' claims. It would be cost prohibitive for an individual plaintiff to conduct discovery against a manufacturer on this scale. Steering Committees, consisting of attorneys from across the country, who are well versed in the particular aspects of the litigation, direct the discovery on behalf of all the plaintiffs. At the conclusion of the discovery process, the judge, with the input of the Steering Committee and the attorneys representing the manufacturer, select a handful of representative cases to be tried. These cases are referred to as bellwether cases. The goal of the court is to see how a jury will evaluate these representative cases so that information will lead to a settlement of the entire MDL suit. If a settlement is reached, there is typically a structure which pays out different amounts to different claimants based on the injuries sustained. Each claimant has the right to either accept or reject the offered settlement. If the claimant elects to reject the settlement, their particular case is sent to their home state to be tried just as if it had been filed in that state from the start.